CXCL8 and prostate carcinoma: The research team led by Shen [19] did not prove that miR-106a-5p directly affects the Wnt/β-catenin pathway in prostate cancer, but they did demonstrate a role for this miRNA in association with interleukin-8, which may affect the activity of the canonical Wnt pathway.